Extracellular vesicles in cancers: mechanisms, biomarkers, and therapeutic strategies
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Extracellular vesicles (EVs) are key in cancer development and intercellular communication. Research explores their role in diagnosis, treatment, and as delivery vehicles for novel anticancer therapies.
Area Of Science
- Oncology
- Cell Biology
- Biochemistry
Background
- Extracellular vesicles (EVs) mediate intercellular communication through transfer of proteins, nucleic acids, lipids, and metabolites.
- EVs, including exosomes and microvesicles, differ in formation and secretion mechanisms.
- Altered EV quantity and composition are implicated in cancer progression, including oncogenic signaling, angiogenesis, metabolic reprogramming, and immunosuppression.
Purpose Of The Study
- To review the role of EV-contained biomolecules in cancer progression and the tumor microenvironment.
- To explore the potential of EV-based liquid biopsy for cancer diagnosis and treatment monitoring.
- To discuss the application of EVs as delivery vehicles and vaccines for antitumor strategies.
Main Methods
- Literature review focusing on the biological functions of EVs in cancer.
- Analysis of EV isolation technologies and characterization methods.
- Exploration of clinical applications and ongoing trials for EV-based cancer therapies.
Main Results
- EVs facilitate cancer development through various mechanisms, including signal transfer and immune evasion.
- Advancements in EV technology enhance their utility in early cancer diagnosis and treatment evaluation.
- EVs show promise as drug delivery systems and in vaccine development for cancer treatment.
Conclusions
- EVs are crucial players in cancer biology and hold significant potential for clinical applications.
- EV-based liquid biopsy and targeted delivery offer innovative approaches to cancer management.
- Further research and clinical trials are necessary to overcome limitations and optimize EV-based anticancer therapies.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...